A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).
Clinical trial NCT00441558 · TERMINATED
Trial details
- NCT number
- NCT00441558
- Sponsor
- Sprout Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Primary completion
- 2009-08-01
- Enrollment
- 1723
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.